Patient timing at risk from disconnected steps
Slots, collections, manufacturing, QC, QA, and release get planned separately, so vein to vein or shelf life timing isn’t protected end to end.
QC and CGT planning and scheduling, E2E planning and scheduling, digital planning strategy and design, program management and change adoption.
External manufacturing network extension, network decision governance, risk and resilience, network analytics and control towers.
AI ready data foundation, data quality and master data accuracy, AI roadmap and readiness, enterprise transformation for AI.
Cold chain and specialist fulfillment, perfect fulfillment, integrated network operations, customer centricity
QC supply chain integration, external manufacturing and CDMO maturity, plant effectiveness, advanced manufacturing operator scheduling.
Organizational transformation, change management, readiness based release management, transformation governance and business case.
Cutting X Community
Connect with manufacturing, quality, and supply peers scaling patient specific and commercial biotech operations, including voices from Legend Biotech, Argenx,... and see how others are protecting control while they grow.
Connects supply priorities to capacity plans and schedules for QC, R&D, manufacturing, and advanced therapy operations.
Powers commercial biotech supply planning, connecting demand, inventory, sourcing, regulatory constraints, shelf life, scenarios, and CMO capacity.